Arend von Stackelberg, MD
Charite University, Berlin, Germany · University Hospital of Berlin - Charité
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arend von Stackelberg, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:44 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03590171 · International Study for Treatment of High Risk Childhood Relapsed ALL 2010Charite University, Berlin, Germany · recruiting · Acute Lymphoblastic Leukemia (ALL) · principal investigator
- Ph3NCT01802814 · International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010Charite University, Berlin, Germany · completed · Acute Lymphoblastic Leukemia (ALL) · principal investigator
- Ph1/Ph2NCT01471782 · Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaAmgen Research (Munich) GmbH · completed · Acute Lymphoblastic Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.